Intellectual Property Law
New Matter SPRING 2020, Volume 45, Number 1
Content
- 2020 New Matter Author Submission Guidelines
- AmGen: Markush Practice in 2020
- Case Comments
- Contents
- Copyright News
- Federal Circuit Report
- Intellectual Property Section Executive Committee 2019-2020
- Intellectual Property Section Interest Group Representatives 2019-2020
- Ip and Art: An International Perspective
- Letter from the Chair
- Letter from the Editor-in-Chief
- MCLE Self-Study Article: Bubble, Bubble, Oil-no Trouble?
- MCLE Self-Study Article: Ethics of Social Media For Lawyers: Where Stunting For the Gram Meets Losing Your Bar Card
- Ninth Circuit Report
- Online Cle For Participatory Credit
- Quarterly International Ip Law Update
- The California Lawyers Association Intellectual Property Alumni
- The Licensing Corner
- Ttab Decisions and Developments
- Upcoming Events
- Broad Institute Crispr: Epo Patent Revocation Lessons for Claiming Priority to Provisional Applications
Broad Institute CRISPR: EPO Patent Revocation Lessons for Claiming Priority to Provisional Applications
D. Benjamin Borson
Borson Law Group P.C.
SUMMARY
This article provides a brief summary of the revocation by the EPO of EP 2,771,468 (EP ‘468 patent). The EP ‘468 patent is drawn to use of CRISPR technology for gene editing in eukaryotic cells. The EP ‘468 patent named The Broad Institute, MIT, and Harvard College as Applicants. The patent was opposed by Novozymes A/S, CRISPR Therapeutics GG and others.